Pacific Biosciences of California Inc (NAS:PACB)
$ 1.825 -0.215 (-10.54%) Market Cap: 497.37 Mil Enterprise Value: 912.51 Mil PE Ratio: 0 PB Ratio: 1.01 GF Score: 62/100

Pacific Biosciences of California Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 11, 2022 / 06:00PM GMT
Release Date Price: $7.94 (+3.25%)
Unidentified Analyst

So we're happy for our next -- to host our next panel here. We have Christian Henry, President and CEO of PacBio. It's definitely been an interesting day in the market for PacBio. So love to dig in and just maybe talk more about the story.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Sure, happy to. Thank you for the opportunity to be here.

Questions & Answers

Unidentified Analyst

So maybe just starting off kind of recently on the recent quarter. PacBio load his guidance last week when they reported 2Q earnings. Can you just kind of run through on what changed in your expectations from earlier in the year with the lower guide?

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Yes. I think the biggest thing that we saw or we're seeing in the world is the impact of the broader macroeconomic conditions. And so as many of you know, we sell instrumentation that's high

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot